⚖️ Metabolic

Obesity

Excess body fat that increases risk of diabetes, cardiovascular disease and cancer.

Overview

Obesity is defined by BMI ≥30 (or lower with high-risk ethnicity). It is a chronic, relapsing condition with strong biological drivers. Treatment combines dietary, behavioural and physical activity change; pharmacotherapy and bariatric surgery are options for selected patients.

Symptoms

  • • Often asymptomatic
  • • Breathlessness on exertion
  • • Joint pain
  • • Snoring or sleep apnoea
  • • Reflux

Risk factors

  • • Genetic predisposition
  • • Sedentary lifestyle
  • • Energy-dense diet
  • • Certain medications (steroids, antipsychotics)
  • • Hypothyroidism

Causes

  • • Sustained positive energy balance
  • • Hormonal and genetic factors
  • • Environmental and socioeconomic factors

🚨 Red flags — seek urgent care

  • • Symptoms of obstructive sleep apnoea with daytime sleepiness
  • • Cardiovascular symptoms
  • • Severe mobility loss

When to seek care

  • • BMI ≥30 or weight gain affecting health
  • • Co-existing diabetes, hypertension or sleep apnoea
  • • Considering pharmacotherapy or surgery

Diagnosis

  • • BMI ≥30 (or ≥27.5 in South Asian, Chinese, other high-risk ethnic groups)
  • • Waist circumference for central adiposity (men ≥94 cm, women ≥80 cm — higher in some ethnicities)
  • • Comorbidity screening: BP, lipids, HbA1c, LFTs, sleep apnoea, mood

Treatment

  • • Multicomponent lifestyle programmes: dietary change (calorie deficit), 150–300 min/week activity, behaviour change
  • • Pharmacotherapy: GLP-1 RAs (semaglutide, liraglutide), tirzepatide, orlistat — alongside lifestyle
  • • Bariatric surgery (BMI ≥40, or ≥35 with comorbidity) — sleeve gastrectomy or Roux-en-Y bypass
  • • Treat comorbid hypertension, dyslipidaemia, diabetes, obstructive sleep apnoea
  • • Psychological support; address eating disorders and weight stigma

Prevention

  • • Balanced diet rich in vegetables, fibre and whole grains; limit ultra-processed foods and sugary drinks
  • • Daily physical activity; limit sedentary time
  • • Adequate sleep (≥7 hours)
  • • Address childhood obesity early

Complications

  • • Type 2 diabetes, hypertension, dyslipidaemia
  • • Cardiovascular disease and stroke
  • • Multiple cancers (colorectal, breast, endometrial, oesophageal, pancreatic, kidney)
  • • Obstructive sleep apnoea, NAFLD, gallstones
  • • Osteoarthritis, depression, reduced fertility

Education & self-care

This guidance is reviewed by Dr. Handel Emery, MD, FRCP (UK) and last updated 2026-06-08. It is educational and not a substitute for professional medical advice.

Frequently asked questions

Are weight-loss injections safe?

GLP-1 medicines such as semaglutide are effective and broadly safe under medical supervision. They are not a substitute for sustained lifestyle change.

Are GLP-1 drugs like semaglutide a long-term solution?

They can produce 10–15% weight loss when combined with lifestyle change, but most weight returns if stopped. They are increasingly viewed as long-term treatment rather than short courses.

When is bariatric surgery considered?

Usually for BMI ≥35 with significant complications, or BMI ≥40 alone, after structured weight-loss attempts. It produces durable weight loss and improves or resolves type 2 diabetes in most patients.

Is BMI a fair measure?

BMI is a useful screen but does not capture muscle mass, fat distribution or ethnicity. Waist circumference, body composition and metabolic markers add a more complete picture.

Medically reviewed by Dr. Handel Emery, MD, FRCP (UK) · Last reviewed 2026-06-08